Soluble CD4 and CD8 in serum from patients with localized scleroderma

Area of Science:

• Immunology
• Dermatology
• Autoimmune Diseases

Background:

• Localized scleroderma is associated with immune system abnormalities.
• Understanding T-cell activation is crucial for localized scleroderma research.

Purpose of the Study:

• To investigate the levels of soluble CD4 (sCD4) and soluble CD8 (sCD8) in patients with localized scleroderma.
• To explore the functional status of CD4+ and CD8+ T cells in different subtypes of localized scleroderma.
• To compare immune profiles of generalized morphea with systemic sclerosis (SSc).

Main Methods:

• Serum samples from 49 localized scleroderma patients (15 generalized morphea, 22 linear scleroderma, 12 morphea) were analyzed.
• Enzyme-linked immunosorbent assay (ELISA) was used to measure sCD4 and sCD8 levels.
• Antibody positivity (IgG anti-ssDNA, antinuclear antibodies, IgM antihistone, rheumatoid factor) and sCD23 levels were assessed.

Main Results:

• Significantly elevated sCD4 and sCD8 levels were observed in patients with generalized morphea.
• Generalized morphea patients had higher sCD4 levels compared to systemic sclerosis (SSc) patients.
• Elevated sCD4 correlated with increased IgG anti-single-stranded DNA (ssDNA) antibody positivity.
• Elevated sCD8 correlated with increased positivity for antinuclear antibodies, IgM antihistone antibodies, IgG anti-ssDNA antibody, rheumatoid factor, and elevated sCD23 levels.

Conclusions:

• Both CD4+ and CD8+ T cells are activated in vivo in generalized morphea.
• The immunological mechanisms in generalized morphea appear distinct from those in SSc.
• These findings highlight potential differences in T-cell involvement across scleroderma subtypes.